A while back I blogged about a study that showed promising results for an injectable treatment for osteoporosis.
The FDA has now approved it!
This is a great development for the treatment of osteoporosis! With the bisphosphonates being hard to take orally this will really help a lot of people. Of course, prevention is best when possible – so remember to get enough calcium everyday and to do some type of weight bearing exercise.
More information about Boniva :
Boniva was approved by the FDA yesterday for use in the treatment of postmenopausal osteoporosis. Boniva
– ibandronate sodium – is given as a injection 4 times a year. It is a type of bisphosphonate drug which is very effective for treating osteoporosis but is difficult to take orally. Supplemental calcium and vitamin D are given to patients getting the injections also.
Boniva, marketed as Bonviva in Europe, should become available for women sometime this year.
In the United States there are around 10 million people (80% women) who are believed to have
osteoporosis. And it has been estimated that nearly 34 million more people may be at a high risk for getting it.
Boniva has been co-developed and promoted by F. Hoffmann-La Roche (Roche) and GlaxoSmithKline (GSK).
If you like this post please share or vote for it below:
- Study unveils new treatment options for osteoporosis!
- May is Osteoporosis Awareness and Prevention Month!
- Corticosteroids and osteoporosis
3 Responses to 'FDA approves an injectable form of Boniva for treatment of osteoporosis!'
Leave a Reply
Comments protected by Lucia's Linky Love.